WSA
ALPN

Wall Street Associates’s Alpine Immune Sciences Inc ALPN Stock Holding History

Wall Street Associates’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-42,600
Closed -$1.39M – 214
2016
Q3 		$1.39M Hold
42,600
– – 0.47% 90
2016
Q2 		$784K Hold
42,600
– – 0.31% 103
2016
Q1 		$711K Hold
42,600
– – 0.3% 111
2015
Q4 		$1.32M Hold
42,600
– – 0.37% 92
2015
Q3 		$2.21M Sell
42,600
-5,500
-11% -$361K 0.42% 76
2015
Q2 		$2.92M Buy
+48,100
New +$2.87M 0.27% 108

Other funds holding ALPN

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wall Street Associates's ALPN Position: Q4 2016 in Review

Wall Street Associates sold out of Alpine Immune Sciences Inc (ALPN) in Q4 2016, closing a stake of 42,600 shares — an estimated $1.39M sold.

Wall Street Associates first reported a position in ALPN in Q2 2015 and held it in 6 quarters. The position peaked at $2.92M in Q2 2015. 38 funds tracked by Wall St. Rank hold ALPN as of Q4 2016.

  • Wall Street Associates reported no remaining Alpine Immune Sciences Inc position as of Q4 2016 after selling out during the quarter.
  • Wall Street Associates sold 42,600 Alpine Immune Sciences Inc shares in Q4 2016, an estimated $1.39M.
  • Wall Street Associates first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 6 quarters.
  • Wall Street Associates's Alpine Immune Sciences Inc position peaked at $2.92M in Q2 2015.
  • 38 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q4 2016.

Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.